RHOA Gene: Structure, Function, and Clinical Significance

A comprehensive guide to the RHOA gene, its protein product, associated diseases, and mutation landscape.

Gene Information Card

Symbol RHOA
Full Name ras homolog family member A
Gene Type protein coding
Chromosomal Location 3p21.31
NCBI Gene ID 387 ncbi.nlm.nih.gov/gene/387
Ensembl ID ENSG00000067560
UniProt ID P61586
OMIM ID 165390
HGNC ID 667
Aliases ARHA, ARH12, RHO12, RHOH12

Description

RHOA (ras homolog family member A) is a small GTPase protein that belongs to the Rho family of GTPases. It acts as a molecular switch, cycling between an active GTP-bound state and an inactive GDP-bound state. RHOA regulates a wide range of cellular processes including actin cytoskeleton organization, cell migration, proliferation, and gene expression. Dysregulation of RHOA signaling is implicated in various cancers and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) Activating mutations (e.g., G17V) or overexpression lead to increased cell proliferation, migration, and invasion. COSMIC, ClinVar, literature
Developmental disorders Germline mutations can cause syndromic conditions, though specific phenotypes are still being characterized. OMIM, literature
Cardiovascular disease RHOA signaling contributes to vascular smooth muscle contraction and endothelial barrier function; dysregulation is linked to hypertension and atherosclerosis. Literature

Expression Profile

Tissue Expression
Tissue nTPM level
Brain High High
Heart Medium Medium
Lung Medium Medium
Liver Medium Medium
Kidney Medium Medium
Testis High High
Cell Line Expression
Cell Line nTPM Notes
HeLa High Cervical cancer cell line
A549 High Lung carcinoma cell line
MCF7 Medium Breast cancer cell line
HepG2 Medium Liver cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
G17V Missense ~5-10% in angioimmunoblastic T-cell lymphoma (AITL) Gain-of-function; impairs GTP hydrolysis, leading to constitutive activation
Y42C Missense Rare Gain-of-function; alters GTP binding affinity
L57V Missense Rare Gain-of-function; disrupts interaction with regulators
R5Q Missense Rare Loss-of-function; reduces GTP binding
Mutation functional classification

Loss of Function (LOF)

Mutations that impair GTP binding or hydrolysis, reducing RHOA activity. These are less common and may act as tumor suppressors in some contexts.

Gain of Function (GOF)

Mutations that lock RHOA in the active GTP-bound state, leading to constitutive signaling. These are oncogenic and promote cell proliferation and migration.

Dominant Negative (DN)

Mutations that produce a protein that binds GDP but cannot exchange to GTP, thereby sequestering upstream activators and blocking signaling from wild-type RHOA.

Gene Ontology (GO)

• GTP binding • GTPase activity
• Protein binding • Signal transduction
• Actin cytoskeleton organization • Cell migration
• Cell proliferation • Apoptosis

Pathways

RhoA signaling pathway
Actin cytoskeleton regulation
Cell cycle
MAPK signaling
Cytokine-cytokine receptor interaction

Protein Summary

RHOA is a 22 kDa protein consisting of 193 amino acids. It contains conserved G-domains for GTP/GDP binding and a C-terminal CAAX motif for membrane anchoring. RHOA cycles between active (GTP-bound) and inactive (GDP-bound) states, regulated by GEFs, GAPs, and GDIs. Active RHOA interacts with effectors such as ROCK, mDia, and PKN to modulate actin dynamics and gene transcription. Post-translational modifications, including prenylation and phosphorylation, regulate its localization and activity.

Related Products

Product name Cat.No. Species Gene ID
RHOA Knockout HEK293 Cell Line EDJ-KQ50130 Human 387 Details Get a Quote
RHOA Knockout HeLa Cell Line EDJ-KQ52654 Human 387 Details Get a Quote
RHOA Knockout A-549 Cell Line EDJ-KQ61128 Human 387 Details Get a Quote
RHOA Knockout HCT 116 Cell Line EDJ-KQ69615 Human 387 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: